Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 8, 2011, Pages 1082-1086

  Bakeera Kitaka, Sabrina ^a,b,c   Conesa Botella, A ^d   Dhabangi, A ^b   Maganda, A ^b   Kekitiinwa, A ^b,e   Colebunders, R ^d   Boulware, David R ^c,e  

^a MAKERERE UNIVERSITY   (Uganda)

^b Paediatric Infectious Diseases Clinic   (Uganda)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; Antiretroviral therapy; Children; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SURVIVAL RATE; TREATMENT DURATION; TUBERCULIN TEST; UGANDA;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS; UGANDA;

EID: 79960419979     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0538     Document Type: Article

References (14)

1. Donald P R, Maher D, Qazi S. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes. Int J Tuberc Lung Dis 2007; 11: 370-380. (Pubitemid 46595765)
2. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402. (Pubitemid 38624845)
3. Rieder H L. Epidemiology of tuberculosis in children. Annales Nestlé 1997; 55: 1-9.
4. Swaminathan S. Tuberculosis in HIV-infected children. Paediatr Respir Rev 2004; 5: 225-230. (Pubitemid 39022861)
5. Martinson N A, Moultrie H, van N R, et al. HAART and risk of tuberculosis in HIV-infected South African children: a multisite retrospective cohort. Int J Tuberc Lung Dis 2009; 13: 862-867.
6. Moyo S, Verver S, Mahomed H, et al. Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa. Int J Tuberc Lung Dis 2010; 14: 149-154.
7. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2007. Geneva, Switzerland: WHO, 2007. http://www.who.int/hiv/mediacentre/universal-access- progress-report-en.pdf Accessed April 2011.
8. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO, 2007. www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf Accessed May 2011.
9. Graham S M, Coulter J B, Gilks C F. Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis 2001; 5: 12-23. (Pubitemid 32401871)
10. Yotebieng M, Van Rie A, Moultrie H, et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS 2010; 24: 1341-1349.
11. Reitz C, Coovadia A, Ko S, et al. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis 2010; 201: 1121-1131.
12. Kamya M R, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 46: 187-193. (Pubitemid 47482614)
13. Raguenaud M E, Isaakidis P, Zachariah R, et al. Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr 2009; 9: 54.
14. Rennert W P, Kilner D, Hale M, Stevens G, Stevens W, Crewe-Brown H. Tuberculosis in children dying with HIV-related lung disease: clinical-pathological correlations. Int J Tuberc Lung Dis 2002; 6: 806-813. (Pubitemid 34988051)